Controversies and future approaches
- 286 Downloads
Cardiology is a rapidly moving field that has recently seen significant medical and invasive advances. This has resulted in improved patient outcomes. While this is good, we are reminded that there are numerous areas in the management of ACS that remain somewhat controversial or unsettled. This uncertainty in the optimal management of unstable coronary patients is a fertile area for continued debate and future research. In this chapter, the first area of discussion is optimal reperfusion therapy for ST-elevation myocardial infarction, followed by optimal revascularization for non-ST-elevation myocardial infarction. The last section touches upon future approaches to the management of cardiovascular disease.
KeywordsPercutaneous Coronary Intervention Acute Coronary Syndrome Percutaneous Coronary Interven Late Stent Thrombosis Future Approach
Unable to display preview. Download preview PDF.
- 2.FINESSE: Abciximab-only-and lytic/abciximab-facilitated PCI no better than primary PCI. Available at: www. theheart.org/article/809837.do. Last accessed December 2007.Google Scholar
- 5.Boden WE, O’Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med 1998; 338:1785–1792. Erratum in: N Engl J Med 1998; 339:1091.CrossRefGoogle Scholar
- 6.Cannon CP, Weintraub WS, Demopoulos LA, et al.; TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)—Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344:1879–1887.CrossRefGoogle Scholar
- 9.Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction. Circulation 2007; 116:803–877.CrossRefGoogle Scholar
- 21.OASIS-5 Trial Group. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006; 354:1464–1476.Google Scholar
- 26.Canon CP, Husted S, Harrington RA, et al. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial. J Am Coll Cardiol 2007; 50:1844–1851.CrossRefGoogle Scholar